System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Pierre-Marie Roy is an expert in Hematology at Centre Hospitalier Universitaire d'Angers (France). As of October 2026, ScienceLeadR ranks Pierre-Marie Roy in the top 1% of experts worldwide for Pulmonary Embolism, Embolism and Thrombosis and Coronavirus Infections. Pierre-Marie Roy has authored 243 publications, the most recent in 2026, and is an investigator in 40 clinical trials, 4 of them ongoing. SLR score: 1,623 (community average: 125). How the SLR is computed.

LeadR Profile

Pierre-Marie Roy Centre Hospitalier Universitaire d'Angers France
1 623 ScienceLeadR Reputation 1623

Unlock

Register Login
Network Map

Hematology

Subspecialties: Critical Care - Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026
Source: PubMed

Centre Hospitalier Universitaire d'Angers

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 243

Citations

Citations: 17 962 1st author: 29 Last author: 38 Unique author: 2

Main journals

J Thromb Haemost 20
Thromb Res 13
Ann Intern Med 9
Lancet 8
Ann Fr Med Urgence 7

Best Journals

Lancet 6
N Engl J Med 5
Eur Heart J 4

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Expanding outpatient eligibility using a narrow definition of cancer in the Pulmonary Embolism Severity Index.
PMID 42657321 — embolism, risk assessment, retrospective studies, neoplasms, cohort studies, pulmonary embolism, ambulatory care, outpatients		Res Pract Thromb Haemost20260
Comparison of Three Diagnostic Strategies for Suspicion of Pulmonary Embolism: Planar Ventilation-Perfusion Scan (V/Q), Computed Tomography Pulmonary Angiography (CTPA), and Single Photon Emission Computed Tomography Ventilation-Perfusion Scan (SPECT V/Q): a multicenter, non-inferiority randomised controlled trial.
PMID 41927066 — embolism, respiration, tomography, ventilation-perfusion scan, angiography, tomography, emission-computed, single-photon, work, pulmonary embolism, diagnosis, ventilation, tomography, emission-computed		Eur Respir J20260
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis.
PMID 41490105 — probability, thrombosis, veins		JAMA Top journal20260
Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysis.
PMID 41354153 — research design, embolism, safety, incidence, clinical decision rules, neoplasms, algorithms, pulmonary embolism, thrombosis		J Thromb Haemost20250
Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Patients with Chronic Lung Disease: An Individual-Patient Data Meta-Analysis.
PMID 41161416 — lung, embolism, safety, pulmonary disease, chronic obstructive, pulmonary embolism, thrombosis, lung diseases		J Thromb Haemost20250

Clinical Studies 40

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 11 Study Chair: 3

By phase:

N/A 24
Phase 3 12
Phase 4 4

By status:

Completed 31
Recruiting 3
Terminated 2
Unknown 2
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 29
Observational 11

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 4
multicentric5to9 2
multicentricup10 29

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
HOME PE2 Home Treatment Versus Hospitalization in Patients With Acute Pulmonary Embolism no Clinical Severity Criteria and Either Right Ventricular Dysfunction or Elevated Troponin a Randomized Controlled Trial
NCT07506291 — quality of life, embolism, hospitalization, ventricular dysfunction, troponin, ventricular dysfunction, right, pulmonary embolism, diagnosis, therapeutics, outpatients, economics, functional status		N/ANot yet recruiting2026
Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria
NCT07315347 — embolism, neoplasms, lung neoplasms, pulmonary embolism, therapeutics, thrombosis		N/ARecruiting2026
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375 — anticoagulants, thromboembolism, embolism, coronary artery disease, pharmaceutical preparations, cardiovascular diseases, venous thrombosis, clopidogrel, aspirin, secondary prevention, pulmonary embolism, therapeutics, venous thromboembolism, thrombosis, direct-acting oral anticoagulants		Phase 3Recruiting2023
Pulmonary Embolism International THrOmbolysis Study 3
NCT04430569 — embolism, plasminogen, plasminogen activators, tissue plasminogen activator, pulmonary embolism, therapeutics, tissues, infusions, intravenous		Phase 3Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS